Clinical Study
A Precision-Driven Approach to Molecular Diagnostics: The Right Test for the Right Patient at the Right Time
HealthTrackRx • Published: May 14, 2026 • Last Reviewed: May, 2026
Urgent care leaders operate in an environment defined by speed, variability, and increasing scrutiny. Clinical accuracy, regulatory compliance, and financial performance must all be maintained simultaneously, often within compressed decision-making windows.
A recent Urgent Care Association presentation, “Faster Smarter, Simpler: How Molecular Diagnostics are Reshaping Efficiency in Treating Urgent Care Infections,” outlines how diagnostic strategy is not a secondary consideration, but a core driver of clinical confidence, operational consistency, and overall performance.
Moving Beyond Testing: A Diagnostic Ecosystem
A precision-driven approach to molecular diagnostics is not about choosing one testing modality over another. It is about designing a comprehensive diagnostic ecosystem.
This model integrates:
- Point-of-care (POC) testing for immediate, high-confidence answers
- Molecular send-out diagnostics for deeper, more definitive insight
- Clinical decision support to guide when and how each is used
According to Lisa Bishop, Founder of Documed Consulting, VP of the College of Urgent Care Medicine, and President-elect of the Southeast Regional Urgent Care Association, the goal is to combine speed and diagnostic depth into a unified approach that supports both providers and patients.
The result is a system that delivers:
- Fast answers when uncertainty is high
- Definitive answers when complexity increases
- Consistency across providers, locations, and patient populations
Precision Is the Foundation of Diagnostic Strategy
A precision-driven model treats diagnostics as operational infrastructure rather than an add-on.
When applied intentionally, molecular diagnostics:
- Strengthen confidence in diagnosis and treatment decisions
- Reduce variability across providers and sites
- Align care with evidence-based guidelines and payor expectations
When applied without structure, they introduce:
- Unnecessary utilization and cost
- Compliance and audit exposure
- Inconsistent and potentially inappropriate clinical decision-making
Precision is not about testing more. It is about testing with intent.
Where Send-Out Molecular Diagnostics Add Value
Send-out molecular diagnostics are most effective when used to reduce uncertainty in clinically ambiguous scenarios.
High-Value Use Cases
A precision-driven approach prioritizes molecular testing when diagnostic clarity directly impacts care:
- Overlapping or non-specific respiratory symptoms
- Pediatric presentations where symptoms may be less definitive
- Recurrent visits or unresolved infections
- Antibiotic decision points where empiric treatment carries downstream risk
In these cases, next-morning diagnostic insight enables more confident, targeted care decisions.
“We’re not replacing point-of-care testing. We’re combining it with molecular diagnostics to create a more complete diagnostic ecosystem—fast answers when you need them, and deeper insight when it matters most,” says Bishop.
Where Point-of-Care Testing Remains Essential
Point-of-care testing continues to be the right choice when:
- Clinical presentation strongly indicates a specific diagnosis
- Immediate treatment decisions are required
- Rapid, high-confidence results are sufficient
A precision-driven strategy ensures each testing modality is used where it delivers the most value, rather than overextending on approach.
Why Next-Morning Results Change Decision-Making
Traditional lab turnaround times can delay clarity by several days. In contrast, next-morning molecular diagnostics provide timely, actionable insight.
This shift enables providers to:
- Move from uncertain, immediate decisions to informed, targeted care
- Reduce unnecessary empiric prescribing
- Adjust treatment quickly when needed
Ben Francis, VP of Procurement and Facilities at Fast Pace Health, explains, “When you can move from waiting several days to having a definitive answer the next morning, you reduce callbacks, improve patient experience, and give providers the ability to make more targeted decisions.”
Faster answers do not just improve efficiency. They improve the quality of care.
Precision Also Means Knowing When Not to Test
An effective diagnostic strategy is defined as much by restraint as it is by action.
Common sources of risk include:
- Broad panel testing without symptom alignment
- Routine testing without clear clinical justification
- Utilization patterns driven by volume rather than medical necessity
These practices increase audit exposure, strain payor relationships, and dilute clinical credibility.
Precision reduces unnecessary variability and reinforces trust among stakeholders. Which is why it’s critical to partner with labs that are fully aligned with medical guidelines and payor policy: to reduce over-testing/over-treatment and to help control the cost of care for payors and patients.
The Operational Impact of Diagnostic Precision
A well-designed diagnostic strategy delivers measurable value across the organization.
For Patients
- Faster, more definitive answers
- Reduced uncertainty and follow-up interactions
- More accurate treatment from the start
For Providers
- Greater confidence in diagnosis and treatment decisions
- Reduced reliance on empiric prescribing
- Improved antibiotic stewardship over time
Providers also begin to recognize patterns in viral and bacterial infections, supporting more informed decision-making.
For Operations and Staff
- Fewer callbacks and administrative burden
- Simplified workflows and training
- Reduced specimen errors and recollection events
Reducing Risk Through Diagnostic Certainty
Lack of diagnostic clarity can lead to unnecessary treatment decisions.
Bishop shared one example: a patient who did not meet clinical criteria for bacterial infection was still treated empirically with antibiotics. A follow-up result later confirmed a viral infection, necessitating treatment discontinuation and illustrating how uncertainty contributes to inappropriate antibiotic use and resistance.
Precision-driven diagnostics help prevent these scenarios by enabling more accurate, timely decision-making.
Diagnostics as a Strategic Advantage
When implemented with precision, molecular diagnostics become a strategic lever that supports:
- More accurate and confident diagnoses
- Operational consistency across sites
- Financial discipline through appropriate utilization
- Reduced administrative burden and improved patient experience
In an environment defined by both speed and scrutiny, this level of alignment is essential.
Enabling a Precision-Driven Approach
HealthTrack enables urgent care providers to diagnose and treat infections faster, with confidence, precision, and clinical clarity. Through a precision-driven model supported by our Medical Science Liaison team, structured decision-support tools, and menu-based pathways, providers can select the right test for the right patient at the right time. Our physician-developed syndromic panels connect symptoms to the most relevant pathogens using specialty-specific menus designed for outpatient care, with next-morning results delivered alongside guideline-aligned treatment insights so you can treat right the first time.
Related Articles and White papers
HealthTrackRx • Published: May 14, 2026 • Last Reviewed: May, 2026
Urgent care leaders operate in an environment defined by speed, variability, and increasing scrutiny. Clinical accuracy, regulatory compliance, and financial performance must all be maintained simultaneously, often within compressed decision-making windows.
A recent Urgent Care Association presentation, “Faster Smarter, Simpler: How Molecular Diagnostics are Reshaping Efficiency in Treating Urgent Care Infections,” outlines how diagnostic strategy is not a secondary consideration, but a core driver of clinical confidence, operational consistency, and overall performance.
Moving Beyond Testing: A Diagnostic Ecosystem
A precision-driven approach to molecular diagnostics is not about choosing one testing modality over another. It is about designing a comprehensive diagnostic ecosystem.
This model integrates:
- Point-of-care (POC) testing for immediate, high-confidence answers
- Molecular send-out diagnostics for deeper, more definitive insight
- Clinical decision support to guide when and how each is used
According to Lisa Bishop, Founder of Documed Consulting, VP of the College of Urgent Care Medicine, and President-elect of the Southeast Regional Urgent Care Association, the goal is to combine speed and diagnostic depth into a unified approach that supports both providers and patients.
The result is a system that delivers:
- Fast answers when uncertainty is high
- Definitive answers when complexity increases
- Consistency across providers, locations, and patient populations
Precision Is the Foundation of Diagnostic Strategy
A precision-driven model treats diagnostics as operational infrastructure rather than an add-on.
When applied intentionally, molecular diagnostics:
- Strengthen confidence in diagnosis and treatment decisions
- Reduce variability across providers and sites
- Align care with evidence-based guidelines and payor expectations
When applied without structure, they introduce:
- Unnecessary utilization and cost
- Compliance and audit exposure
- Inconsistent and potentially inappropriate clinical decision-making
Precision is not about testing more. It is about testing with intent.
Where Send-Out Molecular Diagnostics Add Value
Send-out molecular diagnostics are most effective when used to reduce uncertainty in clinically ambiguous scenarios.
High-Value Use Cases
A precision-driven approach prioritizes molecular testing when diagnostic clarity directly impacts care:
- Overlapping or non-specific respiratory symptoms
- Pediatric presentations where symptoms may be less definitive
- Recurrent visits or unresolved infections
- Antibiotic decision points where empiric treatment carries downstream risk
In these cases, next-morning diagnostic insight enables more confident, targeted care decisions.
“We’re not replacing point-of-care testing. We’re combining it with molecular diagnostics to create a more complete diagnostic ecosystem—fast answers when you need them, and deeper insight when it matters most,” says Bishop.
Where Point-of-Care Testing Remains Essential
Point-of-care testing continues to be the right choice when:
- Clinical presentation strongly indicates a specific diagnosis
- Immediate treatment decisions are required
- Rapid, high-confidence results are sufficient
A precision-driven strategy ensures each testing modality is used where it delivers the most value, rather than overextending on approach.
Why Next-Morning Results Change Decision-Making
Traditional lab turnaround times can delay clarity by several days. In contrast, next-morning molecular diagnostics provide timely, actionable insight.
This shift enables providers to:
- Move from uncertain, immediate decisions to informed, targeted care
- Reduce unnecessary empiric prescribing
- Adjust treatment quickly when needed
Ben Francis, VP of Procurement and Facilities at Fast Pace Health, explains, “When you can move from waiting several days to having a definitive answer the next morning, you reduce callbacks, improve patient experience, and give providers the ability to make more targeted decisions.”
Faster answers do not just improve efficiency. They improve the quality of care.
Precision Also Means Knowing When Not to Test
An effective diagnostic strategy is defined as much by restraint as it is by action.
Common sources of risk include:
- Broad panel testing without symptom alignment
- Routine testing without clear clinical justification
- Utilization patterns driven by volume rather than medical necessity
These practices increase audit exposure, strain payor relationships, and dilute clinical credibility.
Precision reduces unnecessary variability and reinforces trust among stakeholders. Which is why it’s critical to partner with labs that are fully aligned with medical guidelines and payor policy: to reduce over-testing/over-treatment and to help control the cost of care for payors and patients.
The Operational Impact of Diagnostic Precision
A well-designed diagnostic strategy delivers measurable value across the organization.
For Patients
- Faster, more definitive answers
- Reduced uncertainty and follow-up interactions
- More accurate treatment from the start
For Providers
- Greater confidence in diagnosis and treatment decisions
- Reduced reliance on empiric prescribing
- Improved antibiotic stewardship over time
Providers also begin to recognize patterns in viral and bacterial infections, supporting more informed decision-making.
For Operations and Staff
- Fewer callbacks and administrative burden
- Simplified workflows and training
- Reduced specimen errors and recollection events
Reducing Risk Through Diagnostic Certainty
Lack of diagnostic clarity can lead to unnecessary treatment decisions.
Bishop shared one example: a patient who did not meet clinical criteria for bacterial infection was still treated empirically with antibiotics. A follow-up result later confirmed a viral infection, necessitating treatment discontinuation and illustrating how uncertainty contributes to inappropriate antibiotic use and resistance.
Precision-driven diagnostics help prevent these scenarios by enabling more accurate, timely decision-making.
Diagnostics as a Strategic Advantage
When implemented with precision, molecular diagnostics become a strategic lever that supports:
- More accurate and confident diagnoses
- Operational consistency across sites
- Financial discipline through appropriate utilization
- Reduced administrative burden and improved patient experience
In an environment defined by both speed and scrutiny, this level of alignment is essential.
Enabling a Precision-Driven Approach
HealthTrack enables urgent care providers to diagnose and treat infections faster, with confidence, precision, and clinical clarity. Through a precision-driven model supported by our Medical Science Liaison team, structured decision-support tools, and menu-based pathways, providers can select the right test for the right patient at the right time. Our physician-developed syndromic panels connect symptoms to the most relevant pathogens using specialty-specific menus designed for outpatient care, with next-morning results delivered alongside guideline-aligned treatment insights so you can treat right the first time.
Related Articles and White papers
